Analyze Diet
International journal of molecular sciences2023; 24(23); 16778; doi: 10.3390/ijms242316778

Early Castration in Horses Does Not Impact Osteoarticular Metabolism.

Abstract: The castration of stallions is traditionally performed after puberty, at around the age of 2 years old. No studies have focused on the effects of early castration on osteoarticular metabolism. Thus, we aimed to compare early castration (3 days after birth) with traditional castration (18 months of age) in horses. Testosterone and estradiol levels were monitored from birth to 33 months in both groups. We quantified the levels of biomarkers of cartilage and bone anabolism (CPII and N-MID) and catabolism (CTX-I and CTX-II), as well as of osteoarthritis (HA and COMP) and inflammation (IL-6 and PGE). We observed a lack of parallelism between testosterone and estradiol synthesis after birth and during puberty in both groups. The extra-gonadal synthesis of steroids was observed around the 28-month mark, regardless of the castration age. We found the expression of estrogen receptor (ESR1) in cartilage and bone, whereas androgen receptor (AR) expression appeared to be restricted to bone. Nevertheless, with respect to osteoarticular metabolism, steroid hormone deprivation resulting from early castration had no discernable impact on the levels of biomarkers related to bone and cartilage metabolism, nor on those associated with OA and inflammation. Consequently, our research demonstrated that early castration does not disrupt bone and cartilage homeostasis.
Publication Date: 2023-11-26 PubMed ID: 38069100PubMed Central: PMC10706761DOI: 10.3390/ijms242316778Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study focused on determining the effects of early castration (3 days after birth) vs traditional castration (18 months old) in horses, particularly on osteoarticular (bone and joint) metabolism. Key findings reveal that bone and cartilage metabolism and related hormonal regulation is not significantly affected by the timing of castration.

Study Design and Measurements

The researchers compared two groups of horses – one group underwent early castration, and the other group underwent traditional castration. Key parameters that were monitored include:

  • The levels of testosterone and estradiol, the main male and female sex hormones, respectively, from birth to 33 months of age.
  • The levels of specific biomarkers associated with bone and cartilage anabolism (growth and repair, represented by CPII and N-MID) and catabolism (breakdown, represented by CTX-I and CTX-II).
  • The levels of other markers related to osteoarthritis (HA and COMP) and inflammation (IL-6 and PGE), to determine any potential secondary effects on joint health.

Key Findings

Important observations and results from the study include:

  • There was no distinct pattern observed between testosterone and estradiol synthesis (production) after birth and during puberty in both groups, suggesting that the timing of castration does not significantly alter these hormonal patterns.
  • Synthesis of steroid hormones was observed outside of the gonads (testes), around the 28-month mark, regardless of the age of castration.
  • Estrogen receptors were found in both cartilage and bone, while androgen (male hormone) receptors were found to be restricted only to bone.
  • Detrimental effects of hormone deprivation from early castration were not observed. The biomarkers related to bone and cartilage metabolism, as well as those associated with osteoarthritis and inflammation, showed no discernible difference between the early castration and traditional castration groups.

Conclusion

The research concluded that early castration does not disrupt or negatively impact bone and cartilage metabolism, making it a viable alternative to traditional castration without the risk of impairing skeletal development and joint health in horses. This fills previous gaps in the understanding of the effects of early castration on equine bone and joint health.

Cite This Article

APA
Rouge M, Legendre F, Elkhatib R, Delalande C, Cognié J, Reigner F, Barrière P, Deleuze S, Hanoux V, Galéra P, Bouraïma-Lelong H. (2023). Early Castration in Horses Does Not Impact Osteoarticular Metabolism. Int J Mol Sci, 24(23), 16778. https://doi.org/10.3390/ijms242316778

Publication

ISSN: 1422-0067
NlmUniqueID: 101092791
Country: Switzerland
Language: English
Volume: 24
Issue: 23
PII: 16778

Researcher Affiliations

Rouge, Marion
  • Université de Caen-Normandie, OeReCa, 14000 Caen, France.
Legendre, Florence
  • Université de Caen Normandie BIOTARGEN, 14000 Caen, France.
Elkhatib, Razan
  • Université de Caen-Normandie, OeReCa, 14000 Caen, France.
Delalande, Christelle
  • Université de Caen-Normandie, OeReCa, 14000 Caen, France.
Cognié, Juliette
  • INRAE, Université de Tours, Centre de Recherche de Tours, UMR PRC, 37380 Nouzilly, France.
Reigner, Fabrice
  • INRAE, Université de Tours, Centre de Recherche de Tours, UEPAO, 37380 Nouzilly, France.
Barrière, Philippe
  • INRAE, Université de Tours, Centre de Recherche de Tours, UEPAO, 37380 Nouzilly, France.
Deleuze, Stefan
  • Université de Liège, 4000 Liège, Belgium.
Hanoux, Vincent
  • Université de Caen-Normandie, OeReCa, 14000 Caen, France.
Galéra, Philippe
  • Université de Caen Normandie BIOTARGEN, 14000 Caen, France.
Bouraïma-Lelong, Hélène
  • Université de Caen-Normandie, OeReCa, 14000 Caen, France.

Grant Funding

  • EQUISTEM, N80-2014,917CB194 / Fonds Eperon
  • EQUISTEM-G,014CJ061 / GIS CENTAURE equine research
  • Ru00e9gion Normandie
  • Institut Franu00e7ais du Cheval et de l'u00c9quitation
  • Ministu00e8re de l'Enseignement Supu00e9rieur, de la Recherche et de l'Innovation

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 77 references
  1. Carreau S, Genissel C, Bilinska B, Levallet J. Sources of Oestrogen in the Testis and Reproductive Tract of the Male. Int. J. Androl. 1999;22:211–223.
  2. Payne AH, Hales DB. Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones. Endocr. Rev. 2004;25:947–970.
    doi: 10.1210/er.2003-0030pubmed: 15583024google scholar: lookup
  3. Andersson A-M, Toppari J, Haavisto A-M, Petersen JH, Simell T, Simell O, Skakkeb NE. Longitudinal Reproductive Hormone Profiles in Infants: Peak of Inhibin B Levels in Infant Boys Exceeds Levels in Adult Men. J. Clin. Endocrinol. Metab. 1998;83:675–681.
    doi: 10.1210/jc.83.2.675pubmed: 9467591google scholar: lookup
  4. Zirkin BR, Papadopoulos V. Leydig Cells: Formation, Function, and Regulation. Biol. Reprod. 2018;99:101–111.
    doi: 10.1093/biolre/ioy059pmc: PMC6044347pubmed: 29566165google scholar: lookup
  5. Vermeulen A, Kaufman JM, Goemaere S, Van Pottelberg I. Estradiol in Elderly Men. Aging Male 2002;5:98–102.
    doi: 10.1080/tam.5.2.98.102pubmed: 12198740google scholar: lookup
  6. Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K. Analysis of the Human Tissue-Specific Expression by Genome-Wide Integration of Transcriptomics and Antibody-Based Proteomics. Mol. Cell. Proteom. 2014;13:397–406.
    doi: 10.1074/mcp.M113.035600pmc: PMC3916642pubmed: 24309898google scholar: lookup
  7. Cauley JA. Estrogen and Bone Health in Men and Women. Steroids 2015;99:11–15.
  8. Gokhale JA, Frenkel SR, Dicesare PE. Estrogen and Osteoarthritis. Am. J. Orthop. 2004;33:71–80.
    pubmed: 15005596
  9. Lorentzon M, Swanson C, Andersson N, Mellström D, Ohlsson C. Free Testosterone Is a Positive, Whereas Free Estradiol Is a Negative, Predictor of Cortical Bone Size in Young Swedish Men: The GOOD Study: Estradiol predicts cortical bone size in men. J. Bone Miner. Res. 2005;20:1334–1341.
    doi: 10.1359/JBMR.050404pubmed: 16007330google scholar: lookup
  10. Roman-Blas JA, Castañeda S, Largo R, Herrero-Beaumont G. Osteoarthritis Associated with Estrogen Deficiency. Arthritis Res. Ther. 2009;11:241.
    doi: 10.1186/ar2791pmc: PMC2787275pubmed: 19804619google scholar: lookup
  11. Bord S. Estrogen Receptors and Are Differentially Expressed in Developing Human Bone. J. Clin. Endocrinol. Metab. 2001;86:2309–2314.
    doi: 10.1210/jc.86.5.2309pubmed: 11344243google scholar: lookup
  12. Khalid AB, Krum SA. Estrogen Receptors Alpha and Beta in Bone. Bone 2016;87:130–135.
    doi: 10.1016/j.bone.2016.03.016pmc: PMC5336249pubmed: 27072516google scholar: lookup
  13. Nasatzky E, Schwartz Z, Soskolne WA, Brooks BP, Dean DD, Boyan BD, Ornoy A. Evidence for Receptors Specific for 17 Beta-Estradiol and Testosterone in Chondrocyte Cultures. Connect. Tissue Res. 1994;30:277–294.
    doi: 10.3109/03008209409015043pubmed: 7956206google scholar: lookup
  14. Nilsson O, Chrysis D, Pajulo O, Boman A, Holst M, Rubinstein J, Martin Ritzén E, Sävendahl L. Localization of Estrogen Receptors-Alpha and -Beta and Androgen Receptor in the Human Growth Plate at Different Pubertal Stages. J. Endocrinol. 2003;177:319–326.
    doi: 10.1677/joe.0.1770319pubmed: 12740020google scholar: lookup
  15. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and Bone. Endocr. Rev. 2004;25:389–425.
    doi: 10.1210/er.2003-0003pubmed: 15180950google scholar: lookup
  16. Khosla S, Monroe DG. Regulation of Bone Metabolism by Sex Steroids. Cold Spring Harb. Perspect. Med. 2018;8:a031211.
    doi: 10.1101/cshperspect.a031211pmc: PMC5749141pubmed: 28710257google scholar: lookup
  17. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y. Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts. Cell 2007;130:811–823.
    doi: 10.1016/j.cell.2007.07.025pubmed: 17803905google scholar: lookup
  18. Juul A. The Effects of Oestrogens on Linear Bone Growth. Hum. Reprod. Update 2001;7:303–313.
    doi: 10.1093/humupd/7.3.303pubmed: 11392377google scholar: lookup
  19. Tanner JM, Davies PSW. Clinical Longitudinal Standards for Height and Height Velocity for North American Children. J. Pediatr. 1985;107:317–329.
    doi: 10.1016/S0022-3476(85)80501-1pubmed: 3875704google scholar: lookup
  20. Cadogan J, Blumsohn A, Barker ME, Eastell R. A Longitudinal Study of Bone Gain in Pubertal Girls: Anthropometric and Biochemical Correlates. J. Bone Miner. Res. 1998;13:1602–1612.
    doi: 10.1359/jbmr.1998.13.10.1602pubmed: 9783549google scholar: lookup
  21. Lu WP, Cowell T, Lloyd-Jones A, Briody N, Howman-Giles R. Volumetric Bone Mineral Density in Normal Subjects, Aged 5–27 Years. J. Clin. Endocrinol. Metab. 1996;81:1586–1590.
    pubmed: 8636372
  22. Boot AM, de Ridder MAJ, van der Sluis IM, van Slobbe I, Krenning EP, de Muinck Keizer-Schrama SMPF. Peak Bone Mineral Density, Lean Body Mass and Fractures. Bone 2010;46:336–341.
    doi: 10.1016/j.bone.2009.10.003pubmed: 19833245google scholar: lookup
  23. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-Term Effect of Testosterone Therapy on Bone Mineral Density in Hypogonadal Men. J. Clin. Endocrinol. Metab. 1997;82:2386–2390.
    doi: 10.1210/jcem.82.8.4163pubmed: 9253305google scholar: lookup
  24. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2010;95:2536–2559.
    doi: 10.1210/jc.2009-2354pubmed: 20525905google scholar: lookup
  25. Smith E, Korach K. Oestrogen Receptor Deficiency: Consequences for Growth. Acta Paediatr. 1996;85:39–43.
  26. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man. N. Engl. J. Med. 1994;331:1056–1061.
    doi: 10.1056/NEJM199410203311604pubmed: 8090165google scholar: lookup
  27. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER. Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency. N. Engl. J. Med. 1997;337:91–95.
    doi: 10.1056/NEJM199707103370204pubmed: 9211678google scholar: lookup
  28. Moverare S, Venken K, Eriksson A-L, Andersson N, Skrtic S, Wergedal J, Mohan S, Salmon P, Bouillon R, Gustafsson J-A. Differential Effects on Bone of Estrogen Receptor and Androgen Receptor Activation in Orchidectomized Adult Male Mice. Proc. Natl. Acad. Sci. USA 2003;100:13573–13578.
    doi: 10.1073/pnas.2233084100pmc: PMC263855pubmed: 14573701google scholar: lookup
  29. Notini AJ, McManus JF, Moore A, Bouxsein M, Jimenez M, Chiu WM, Glatt V, Kream BE, Handelsman DJ, Morris HA. Osteoblast Deletion of Exon 3 of the Androgen Receptor Gene Results in Trabecular Bone Loss in Adult Male Mice. J. Bone Miner. Res. 2007;22:347–356.
    doi: 10.1359/jbmr.061117pubmed: 17147488google scholar: lookup
  30. Peng Z, Li X, Mäkelä S, Väänänen HK, Poutanen M. Skeletal Changes in Transgenic Male Mice Expressing Human Cytochrome P450 Aromatase. J. Bone Miner. Res. 2004;19:1320–1328.
    doi: 10.1359/JBMR.040510pubmed: 15231020google scholar: lookup
  31. Vico L, Vanacker J-M. Sex Hormones and Their Receptors in Bone Homeostasis: Insights from Genetically Modified Mouse Models. Osteoporos. Int. 2010;21:365–372.
    doi: 10.1007/s00198-009-0963-5pubmed: 19495826google scholar: lookup
  32. Khosla S, Amin S, Orwoll E. Osteoporosis in Men. Endocr. Rev. 2008;29:441–464.
    doi: 10.1210/er.2008-0002pmc: PMC2528848pubmed: 18451258google scholar: lookup
  33. Nevitt MC, Cummings SR, Lane NE, Hochberg MC, Scott JC, Pressman AR, Genant HK, Cauley JA. Association of Estrogen Replacement Therapy with the Risk of Osteoarthritis of the Hip in Elderly White Women. Study of Osteoporotic Fractures Research Group. Arch. Intern. Med. 1996;156:2073–2080.
  34. Mhaouty-Kodja S, Naulé L, Capela D. Sexual Behavior: From Hormonal Regulation to Endocrine Disruption. Neuroendocrinology 2018;107:400–416.
    doi: 10.1159/000494558pubmed: 30326485google scholar: lookup
  35. Eisenhauer KM, McCue PM, Nayden DK, Osawa Y, Roser JF. Localization of Aromatase in Equine Leydig Cells. Domest. Anim. Endocrinol. 1994;11:291–298.
    doi: 10.1016/0739-7240(94)90020-5pubmed: 7956176google scholar: lookup
  36. Raeside JI. The Isolation of Estrone Sulfate and Estradiol-17 Beta Sulfate from Stallion Testes. Can. J. Biochem. 1969;47:811–815.
    doi: 10.1139/o69-124pubmed: 4309376google scholar: lookup
  37. Line SW, Hart BL, Sanders L. Effect of Prepubertal versus Postpubertal Castration on Sexual and Aggressive Behavior in Male Horses. J. Am. Vet. Med. Assoc. 1985;186:249–251.
    pubmed: 4038698
  38. Moll HD, Pelzer KD, Pleasant RS, Modransky PD, May KA. A Survey of Equine Castration Complications. J. Equine Vet. Sci. 1995;15:522–526.
  39. Cognie J, Freret S, Lansade L, Parias C, Barriere P, Gesbert A, Reigner F, Deleuze S. Early Castration in Foals: Consequences on Physical and Behavioural Development. Equine Vet. J. 2023;55:214–221.
    doi: 10.1111/evj.13580pubmed: 35478462google scholar: lookup
  40. Sims NA, Clément-Lacroix P, Minet D, Fraslon-Vanhulle C, Gaillard-Kelly M, Resche-Rigon M, Baron R. A Functional Androgen Receptor Is Not Sufficient to Allow Estradiol to Protect Bone after Gonadectomy in Estradiol Receptor–Deficient Mice. J. Clin. Investig. 2003;111:1319–1327.
    doi: 10.1172/JCI200317246pmc: PMC154447pubmed: 12727923google scholar: lookup
  41. Rouge M, Elkhatib R, Delalande C, Cognié J, Reigner F, Barriere P, Deleuze S, Cousty M, Legendre F, Galera P. Investigation of Equine Testis Contribution to Vitamin D Bioactivation. Domest. Anim. Endocrinol. 2022;79:106691.
  42. Chen L, Wang R, Wang W, Lu W, Xiao Y, Wang D, Dong Z. Hormone Inhibition during Mini-Puberty and Testicular Function in Male Rats. Int. J. Endocrinol. Metab. 2015;13:e25465.
    doi: 10.5812/ijem.25465pmc: PMC4648129pubmed: 26587029google scholar: lookup
  43. Winter JS, Hughes IA, Reyes FI, Faiman C. Pituitary-Gonadal Relations in Infancy: 2. Patterns of Serum Gonadal Steroid Concentrations in Man from Birth to Two Years of Age. J. Clin. Endocrinol. Metab. 1976;42:679–686.
    doi: 10.1210/jcem-42-4-679pubmed: 1262442google scholar: lookup
  44. Jost A, Vigier B, Prépin J, Perchellet JP. Recent Progress in Hormone Research, Proceedings of the 1972 Laurentian Hormone Conference. Elsevier; Amsterdam, The Netherlands: 1973. Studies on Sex Differentiation in Mammals. pp. 1–41.
    pubmed: 4584366
  45. Wilson CA, Davies DC. The Control of Sexual Differentiation of the Reproductive System and Brain. Reproduction 2007;133:331–359.
    doi: 10.1530/REP-06-0078pubmed: 17307903google scholar: lookup
  46. Gao W, Alcauter S, Elton A, Hernandez-Castillo CR, Smith JK, Ramirez J, Lin W. Functional Network Development During the First Year: Relative Sequence and Socioeconomic Correlations. Cereb. Cortex 2015;25:2919–2928.
    doi: 10.1093/cercor/bhu088pmc: PMC4537436pubmed: 24812084google scholar: lookup
  47. Knickmeyer RC, Gouttard S, Kang C, Evans D, Wilber K, Smith JK, Hamer RM, Lin W, Gerig G, Gilmore JH. A Structural MRI Study of Human Brain Development from Birth to 2 Years. J. Neurosci. 2008;28:12176–12182.
  48. Lyall AE, Shi F, Geng X, Woolson S, Li G, Wang L, Hamer RM, Shen D, Gilmore JH. Dynamic Development of Regional Cortical Thickness and Surface Area in Early Childhood. Cereb. Cortex 2015;25:2204–2212.
    doi: 10.1093/cercor/bhu027pmc: PMC4506327pubmed: 24591525google scholar: lookup
  49. Barnes RJ, Nathanielsz PW, Rossdale PD, Comline RS, Silver M. Plasma Progestagens and Oestrogens in Fetus and Mother in Late Pregnancy. J. Reprod. Fertil. Suppl. 1975:617–623.
    pubmed: 1060853
  50. Legacki EL, Ball BA, Corbin CJ, Loux SC, Scoggin KE, Stanley SD, Conley AJ. Equine Fetal Adrenal, Gonadal and Placental Steroidogenesis. Reproduction 2017;154:445–454.
    doi: 10.1530/REP-17-0239pubmed: 28878092google scholar: lookup
  51. Schlinger BA, Lane NI, Grisham W, Thompson L. Androgen Synthesis in a Songbird: A Study of Cyp17 (17alpha-Hydroxylase/C17,20-Lyase) Activity in the Zebra Finch. Gen. Comp. Endocrinol. 1999;113:46–58.
    doi: 10.1006/gcen.1998.7179pubmed: 9882543google scholar: lookup
  52. Witchel SF, Pinto B, Burghard AC, Oberfield SE. Update on Adrenarche. Curr. Opin. Pediatr. 2020;32:574–581.
  53. Turcu AF, Auchus RJ. Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia. Endocrinol. Metab. Clin. N. Am. 2015;44:275–296.
    doi: 10.1016/j.ecl.2015.02.002pmc: PMC4506691pubmed: 26038201google scholar: lookup
  54. Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B. Marked Decline in Serum Concentrations of Adrenal C19 Sex Steroid Precursors and Conjugated Androgen Metabolites during Aging. J. Clin. Endocrinol. Metab. 1997;82:2396–2402.
    doi: 10.1210/jcem.82.8.4160pubmed: 9253307google scholar: lookup
  55. Migeon CJ, Keller AR, Lawrence B, Shepard TH. Dehydroepiandrosterone and Androsterone Levels in Human Plasma: Effect of Age and Sex; Day-to-Day and Diurnal Variations. J. Clin. Endocrinol. Metab. 1957;17:1051–1062.
    doi: 10.1210/jcem-17-9-1051pubmed: 13463066google scholar: lookup
  56. Remer T, Manz F, Hartmann MF, Schoenau E, Wudy SA. Prepubertal Healthy Children’s Urinary Androstenediol Predicts Diaphyseal Bone Strength in Late Puberty. J. Clin. Endocrinol. Metab. 2009;94:575–578.
    doi: 10.1210/jc.2008-1375pubmed: 19001521google scholar: lookup
  57. Holló I, Fehér T, Szücs J. Serum Dehydroepiandrosterone, Androsterone and Cortisol Level in Primary Postmenopausal and Other Type Osteoporosis. Acta Medica Acad. Sci. Hung. 1970;27:155–160.
    pubmed: 4248799
  58. Zhao H, Tian Z, Hao J, Chen B. Extragonadal Aromatization Increases with Time after Ovariectomy in Rats. Reprod. Biol. Endocrinol. 2005;3:6.
    doi: 10.1186/1477-7827-3-6pmc: PMC548297pubmed: 15661083google scholar: lookup
  59. Juliand V, Martin-Rosset W. The Growing Horse: Nutrition and Prevention of Growth Disorders. Volume 114. Wageningen Academic Publishers; Wageningen, The Netherlands: 2005. (EAAP Scientific Series). .
  60. Nelson LR, Bulun SE. Estrogen Production and Action. J. Am. Acad. Dermatol. 2001;45:S116–S124.
    doi: 10.1067/mjd.2001.117432pubmed: 11511861google scholar: lookup
  61. Khosla S, Melton LJ, Atkinson EJ, O’Fallon WM, Klee GG, Riggs BL. Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estrogen. J. Clin. Endocrinol. Metab. 1998;83:2266–2274.
    doi: 10.1210/jcem.83.7.4924pubmed: 9661593google scholar: lookup
  62. Falahati-Nini A, Riggs BL, Atkinson EJ, O’Fallon WM, Eastell R, Khosla S. Relative Contributions of Testosterone and Estrogen in Regulating Bone Resorption and Formation in Normal Elderly Men. J. Clin. Investig. 2000;106:1553–1560.
    doi: 10.1172/JCI10942pmc: PMC381474pubmed: 11120762google scholar: lookup
  63. Verhas M, Schoutens A, L’hermite-Baleriaux M, Dourov N, Verschaeren A, Mone M, Heilporn A. The Effect of Orchidectomy on Bone Metabolism in Aging Rats. Calcif. Tissue Int. 1986;39:74–77.
    doi: 10.1007/BF02553294pubmed: 3091224google scholar: lookup
  64. Irie T, Aizawa T, Kokubun S. The Role of Sex Hormones in the Kinetics of Chondrocytes in the Growth Plate: A study in rabbit. J. Bone Jt. Surg. Br. 2005;87-B:1278–1284.
    doi: 10.1302/0301-620X.87B9.15583pubmed: 16129759google scholar: lookup
  65. Sniekers YH, Weinans H, Bierma-Zeinstra SM, van Leeuwen JPTM, van Osch GJVM. Animal Models for Osteoarthritis: The Effect of Ovariectomy and Estrogen Treatment—A Systematic Approach. Osteoarthr. Cartil. 2008;16:533–541.
    doi: 10.1016/j.joca.2008.01.002pubmed: 18280756google scholar: lookup
  66. Peshkova M, Lychagin A, Lipina M, Di Matteo B, Anzillotti G, Ronzoni F, Kosheleva N, Shpichka A, Royuk V, Fomin V. Gender-Related Aspects in Osteoarthritis Development and Progression: A Review. Int. J. Mol. Sci. 2022;23:2767.
    doi: 10.3390/ijms23052767pmc: PMC8911252pubmed: 35269906google scholar: lookup
  67. Eastell R, Hannon RA. Biomarkers of Bone Health and Osteoporosis Risk. Proc. Nutr. Soc. 2008;67:157–162.
    doi: 10.1017/S002966510800699Xpubmed: 18412989google scholar: lookup
  68. Nagasue K, Inaba M, Okuno S, Kitatani K, Imanishi Y, Ishimura E, Miki T, Kim M, Nishizawa Y. Serum N-Terminal Midfragment vs. Intact Osteocalcin Immunoradiometric Assay as Markers for Bone Turnover and Bone Loss in Hemodialysis Patients. Biomed. Pharmacother. 2003;57:98–104.
    doi: 10.1016/S0753-3322(02)00344-Xpubmed: 12842495google scholar: lookup
  69. Herrmann D, Intemann T, Lauria F, Mårild S, Molnár D, Moreno LA, Sioen I, Tornaritis M, Veidebaum T, Pigeot I. Reference Values of Bone Stiffness Index and C-Terminal Telopeptide in Healthy European Children. Int. J. Obes. 2014;38:S76–S85.
    doi: 10.1038/ijo.2014.138pubmed: 25376222google scholar: lookup
  70. Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Högler W. Sex- and Age-Specific Reference Curves for Serum Markers of Bone Turnover in Healthy Children from 2 Months to 18 Years. J. Clin. Endocrinol. Metab. 2007;92:443–449.
    doi: 10.1210/jc.2006-1706pubmed: 17105843google scholar: lookup
  71. Ambroszkiewicz J, Gajewska J, Rowicka G, Klemarczyk W, Chelchowska M. Assessment of Biochemical Bone Turnover Markers and Bone Mineral Density in Thin and Normal-Weight Children. Cartilage 2018;9:255–262.
    doi: 10.1177/1947603516686145pmc: PMC6042038pubmed: 29156943google scholar: lookup
  72. Bleasel JF, Poole AR, Heinegård D, Saxne T, Holderbaum D, Ionescu M, Jones P, Moskowitz RW. Changes in Serum Cartilage Marker Levels Indicate Altered Cartilage Metabolism in Families with the Osteoarthritis-Related Type II Collagen Gene COL2A1 Mutation. Arthritis Rheum. 1999;42:39–45.
  73. Mouritzen U, Christgau S, Lehmann H-J, Tankó LB, Christiansen C. Cartilage Turnover Assessed with a Newly Developed Assay Measuring Collagen Type II Degradation Products: Influence of Age, Sex, Menopause, Hormone Replacement Therapy, and Body Mass Index. Ann. Rheum. Dis. 2003;62:332–336.
    doi: 10.1136/ard.62.4.332pmc: PMC1754496pubmed: 12634232google scholar: lookup
  74. Hoch JM, Mattacola CG, Medina McKeon JM, Howard JS, Lattermann C. Serum Cartilage Oligomeric Matrix Protein (SCOMP) Is Elevated in Patients with Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Osteoarthr. Cartil. 2011;19:1396–1404.
    doi: 10.1016/j.joca.2011.09.005pmc: PMC3962955pubmed: 22001901google scholar: lookup
  75. Saruga T, Sasaki E, Inoue R, Chiba D, Ota S, Iwasaki H, Uesato R, Nakaji S, Ishibashi Y. Usefulness of Serum Hyaluronic Acid Levels as a Predictor of Incidence of Hand Osteoarthritis Analyzed by Longitudinal Analysis from the Iwaki Cohort. Sci. Rep. 2021;11:4074.
    doi: 10.1038/s41598-021-83693-0pmc: PMC7892545pubmed: 33603120google scholar: lookup
  76. Sasaki E, Tsuda E, Yamamoto Y, Maeda S, Inoue R, Chiba D, Fujita H, Takahashi I, Umeda T, Nakaji S. Serum Hyaluronic Acid Concentration Predicts the Progression of Joint Space Narrowing in Normal Knees and Established Knee Osteoarthritis—A Five-Year Prospective Cohort Study. Arthritis Res. Ther. 2015;17:283.
    doi: 10.1186/s13075-015-0793-0pmc: PMC4600294pubmed: 26453426google scholar: lookup
  77. Bertoni L, Jacquet-Guibon S, Branly T, Legendre F, Desancé M, Mespoulhes C, Melin M, Hartmann D-J, Schmutz A, Denoix J-M. An Experimentally Induced Osteoarthritis Model in Horses Performed on Both Metacarpophalangeal and Metatarsophalangeal Joints: Technical, Clinical, Imaging, Biochemical, Macroscopic and Microscopic Characterization. PLoS ONE 2020;15:e0235251.

Citations

This article has been cited 0 times.